Bobby Korn, MD, PhD
SESSIONS
C011 Face Off: Evidence-Based Debates on Today’s Hottest Injectable Controversies
Mar 29, 2026
•
1:00 PM - 4:00 PM
•
Mile High 2A
DISCLOSURES
Amgen – Consultant (1099 relationship)(Honoraria); argenx – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Genentech – Consultant (1099 relationship)(Honoraria);